Medication Profile · Updated November 2026
Mounjaro (Tirzepatide): Cost, Dosing, and Where to Get It in 2026
I have been on Mounjaro since 2024. I started at 2.5 mg, titrated up through the dose schedule, and track my progress with regular DEXA scans. This page is the resource I wish existed when I was researching the drug before starting. It covers what Mounjaro actually is, what it costs right now, the full dosing schedule, weight loss data from the clinical trials, and where to get it online for the best price.
If you are comparing Mounjaro to other GLP-1s, check out our full four-drug comparison.
Quick Facts
| Detail | Mounjaro |
|---|---|
| Generic Name | Tirzepatide |
| Brand Name | Mounjaro |
| Manufacturer | Eli Lilly and Company |
| Drug Class | Dual GIP/GLP-1 receptor agonist |
| FDA Approval | May 13, 2022 (type 2 diabetes) |
| Administration | Weekly subcutaneous injection (single-dose pen, vial or KwikPen) |
| Available Doses | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Brand Price | As low as $499/month with the Lilly savings card if commercial insurance does not cover it |
| Compounded Tirzepatide | Not FDA-approved. Current prices and legal status |
| With Insurance (Copay) | As little as $25/month with the savings card (commercial plans) |
| Weight Loss (15 mg) | 20.9% body weight at 72 weeks (SURMOUNT-1) |
| Same Molecule As | Zepbound (weight management indication) |
How Mounjaro Works
Mounjaro is a dual GIP/GLP-1 receptor agonist. In plain language, it activates two gut hormones at once: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
GLP-1 slows down how quickly food leaves your stomach, reduces your appetite, and improves how your body uses insulin. This is the same mechanism that Ozempic and Wegovy target.
GIP adds a second layer. It further suppresses appetite and appears to influence how your body stores and metabolizes fat. This dual action is why tirzepatide produces more weight loss than semaglutide (which only targets GLP-1) in clinical trials.
Think of it as two keys turning two locks simultaneously. You get stronger appetite suppression, better blood sugar control, and more fat loss than you would from either mechanism alone.
Mounjaro is FDA-approved specifically for type 2 diabetes. Its label also covers lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes at high risk. Doctors commonly prescribe it off-label for weight loss, and the SURMOUNT trials of the same molecule support that use. I lay out how the diabetes and weight-loss labels differ on dosing and coverage in GLP-1 for type 2 diabetes vs weight loss. If you want a version that is officially approved for weight management, that is Zepbound, which contains the exact same molecule.
For a deeper look at how GLP-1 medications affect your body composition, read our guide on fat loss vs weight loss on GLP-1s.
Dosing Schedule
Per the Mounjaro label, you start at 2.5 mg once weekly. If more blood sugar control is needed, the dose goes up in 2.5 mg steps after at least 4 weeks on the current dose, to a maximum of 15 mg. Going up is not automatic, and the label does not allow faster steps. Your prescriber may keep you at a lower dose longer if side effects are rough. The table shows the fastest schedule the label allows. If your prescriber keeps you at one dose and you think you need more, read what to do when your doctor won’t increase your dose.
| Dose | Duration | Purpose |
|---|---|---|
| 2.5 mg | Weeks 1 to 4 | Starting dose only. Not intended for blood sugar control. |
| 5 mg | Weeks 5 to 8 | First therapeutic dose. Most people start noticing appetite changes here. |
| 7.5 mg | Weeks 9 to 12 | Intermediate dose. Continued weight loss for most patients. |
| 10 mg | Weeks 13 to 16 | Higher dose. 19.5% weight loss in SURMOUNT-1. |
| 12.5 mg | Weeks 17 to 20 | For patients who need additional weight loss beyond 10 mg. |
| 15 mg | Week 21+ | Maximum dose. 20.9% weight loss in SURMOUNT-1. |
A few things I have learned from personal experience: The 2.5 mg starting dose does very little for appetite. Do not get discouraged. The real effects kick in at 5 mg and above. Side effects (mostly nausea) tend to spike in the first week after each dose increase and then settle down. Eating smaller meals and staying hydrated makes a big difference during those transition weeks. Coming from Ozempic? The Ozempic to Mounjaro switching guide covers the new prescription and starting plan.
Label safety points to know before you start: Mounjaro is not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. It can make birth control pills less reliable, so the label advises a non-oral method or adding a barrier method for 4 weeks after starting and after each dose increase. Tell your prescriber if you are pregnant or planning a pregnancy.
For our full dosing breakdown with tips for each level, see the Mounjaro Dosage Guide.
Weight Loss Results: What the Clinical Trials Show
The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, studied tirzepatide in adults with obesity or overweight (BMI of 30 or higher, or 27 or higher with a weight-related condition) who did not have diabetes.
Results at 72 weeks:
| Dose | Avg. Weight Loss | % Losing 20%+ Body Weight |
|---|---|---|
| 5 mg | 15.0% | Not reported in the abstract |
| 10 mg | 19.5% | 50% |
| 15 mg | 20.9% | 57% |
| Placebo | 3.1% | 3% |
For a 220-pound person, the 15 mg average of 20.9% works out to about 46 pounds.
The SURMOUNT-5 trial later confirmed these results in a head-to-head comparison against semaglutide (Wegovy). Tirzepatide produced 20.2% weight loss versus 13.7% for semaglutide over 72 weeks. That is roughly 47% more weight loss with the same molecule that is in Mounjaro.
These are averages, though. Individual results depend on your starting weight, dose, diet, exercise habits, and how long you stay on treatment. Some people respond strongly at lower doses. Others need to reach 12.5 or 15 mg before seeing significant results.
One thing the scale does not tell you: how much of that weight loss is fat versus lean mass. I track this with DEXA scans, and the data has been eye-opening. For more on that, read my DEXA scan results after 6 months on Mounjaro.
What Mounjaro Costs in 2026
Cost is the biggest barrier for most people. Here is a clear breakdown of what you are looking at.
Brand-Name Mounjaro Without Coverage
If your commercial insurance does not cover Mounjaro, Lilly’s savings card lists it as low as $499 for a 1-month fill, with savings of up to $647 a month (checked Nov 4, 2026). Lilly also lists Mounjaro on LillyDirect as self-pay only. Government plan members (Medicare, Medicaid, VA) cannot use the card, and the card expires December 31, 2026.
With Insurance
If your commercial plan covers Mounjaro, the savings card can bring your copay to as little as $25 per month, with up to $150 in savings per monthly fill and $1,950 per year. Coverage is most common when prescribed for type 2 diabetes (the FDA-approved indication). Off-label coverage for weight loss varies widely by plan.
For a full walkthrough of the insurance process, see our GLP-1 insurance coverage guide.
Compounded Tirzepatide
Compounded tirzepatide is not FDA-approved. FDA declared the tirzepatide shortage resolved in December 2024, and the grace periods for compounders ended February 18, 2025 (503A) and March 19, 2025 (503B). Since then, only 503A pharmacies may compound it, in narrow patient-specific cases. See our compounded tirzepatide page for current prices and the questions to ask, and our compounded vs brand-name GLP-1 guide. If you end up on a compounded vial, follow your pharmacy’s instructions exactly. My tirzepatide mg-to-units chart explains why the same mg dose changes with vial strength.
Without Insurance
If you do not have type 2 diabetes and pay cash, Zepbound (the same molecule) is cheaper. Lilly lists the Zepbound KwikPen at $299 (2.5 mg), $399 (5 mg) and $449 (7.5 to 15 mg, with a refill within 45 days) per month.
Our 2026 GLP-1 Cash-Pay Pricing Index tracks more cash-pay programs. See our complete guide on getting GLP-1 medications without insurance.
Looking for the best price on tirzepatide?
Compare 40+ online GLP-1 providers by price and medication options.
Compare Providers →Where to Get Tirzepatide Online
These telehealth providers listed tirzepatide options on their own pages when we checked on November 4, 2026.
| Provider | Listed price | What it offers |
|---|---|---|
| Yucca Health | $258/mo month to month | Compounded tirzepatide (not FDA-approved) |
| MEDVi | $166 to $199/mo (page shows both) | Compounded tirzepatide (not FDA-approved) |
| Ro | $149/mo plus medication | Brand-name GLP-1s, insurance help |
| Mochi Health | $79/mo membership plus medication | Brand-name and compounded options, insurance navigation |
For the full list of 40+ providers with current pricing, visit our provider comparison directory. If affordability is your top priority, our guide on the cheapest GLP-1 options online breaks down every budget-friendly path.
Common Side Effects
The side effects of Mounjaro are mostly gastrointestinal and tend to be worst during the first one to two weeks after each dose increase. They usually improve as your body adjusts.
Most common:
- Nausea (12% to 18% of patients across doses in the placebo-controlled trials on the label, vs 4% on placebo). This was the most noticeable side effect in my experience. It peaked in the first week after moving to a new dose and faded by week two or three.
- Diarrhea (12% to 17%, vs 9% on placebo). More common at higher doses and in the early weeks.
- Constipation (6% to 7%). Some people get the opposite GI issue. Fiber and hydration help.
- Decreased appetite. This is the intended effect, but it can feel extreme in the beginning. Forcing yourself to eat at least some protein at each meal matters for muscle preservation.
- Injection site reactions. Mild redness or itching. Usually minor and temporary.
- Fatigue. Some people report low energy in the first few weeks, especially when eating less than usual.
Serious side effects (rare but worth knowing):
- Pancreatitis (stop the medication and seek medical attention for severe abdominal pain)
- Gallbladder problems (rapid weight loss increases gallstone risk)
- Thyroid C-cell tumors (seen in rodent studies, boxed warning on the label)
- Hypoglycemia (higher risk if combined with insulin or sulfonylureas)
Mounjaro is contraindicated if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
For a more detailed breakdown with management tips, read our GLP-1 side effects guide.
How Mounjaro Compares to Other GLP-1 Drugs
Mounjaro vs Ozempic: Mounjaro (tirzepatide) works on two receptors (GIP + GLP-1) while Ozempic (semaglutide) works on one (GLP-1 only). In the head-to-head SURMOUNT-5 trial, tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide. See our full Mounjaro vs Ozempic comparison.
Mounjaro vs Zepbound: These are the same molecule. Mounjaro is FDA-approved for type 2 diabetes. Zepbound is approved for chronic weight management. Your prescriber will recommend one over the other based on your diagnosis and insurance situation. See our Mounjaro vs Zepbound breakdown.
Mounjaro vs Wegovy: Different molecules, different mechanisms. Mounjaro (dual GIP/GLP-1) outperformed Wegovy (GLP-1 only) in the SURMOUNT-5 head-to-head trial: 20.2% versus 13.7% weight loss. Wegovy has the cardiovascular outcome data advantage from the SELECT trial. Read the full four-way comparison for all the details.
If you are hitting a plateau on Mounjaro, we have a dedicated guide for that: Mounjaro Weight Loss Plateau.
Frequently Asked Questions
Is Mounjaro FDA-approved for weight loss?
No. Mounjaro is FDA-approved for type 2 diabetes only. It is widely prescribed off-label for weight loss, and the clinical trial data (SURMOUNT-1) supports this use. The weight-management-approved version of the same drug is called Zepbound.
What is the difference between Mounjaro and Zepbound?
They are the same molecule (tirzepatide) made by the same company (Eli Lilly). Mounjaro has the type 2 diabetes indication. Zepbound has the chronic weight management indication. Same drug, same doses, different FDA label. Your insurance coverage may differ based on which one is prescribed.
How long does it take for Mounjaro to start working?
Most people notice reduced appetite within the first one to two weeks. Measurable weight loss typically begins within the first month. The SURMOUNT-1 trial showed progressive weight loss continuing through the full 72-week study period. Maximal results tend to come at the 10 to 15 mg doses after several months of treatment.
Can I get Mounjaro without insurance?
Yes. Lilly’s savings card lists Mounjaro as low as $499 a month when commercial insurance does not cover it. If you do not have diabetes, Zepbound (same molecule) costs $299 to $449 a month self-pay. Compounded tirzepatide is cheaper at some programs but is not FDA-approved. See our guide to GLP-1s without insurance for a full walkthrough.
Should I exercise while on Mounjaro?
Yes, and resistance training is especially important. A meaningful share of the weight lost on GLP-1 medications can be lean mass (muscle). Strength training and enough protein help preserve muscle. Ask your clinician or a dietitian for a protein target, especially if you have kidney disease. I have seen this clearly in my own DEXA scan data. Read our guide on exercise and muscle preservation on GLP-1s for specific recommendations.
Last updated: November 2026. Pricing and availability may change. This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.
What we checked
This AI-assisted public-source desk check reviewed the Mounjaro and Zepbound prescribing information, the FDA approval record and compounding policy page, the SURMOUNT-1 and SURMOUNT-5 trial publications, Lilly’s Mounjaro and Zepbound savings pages, and the pricing pages of Yucca Health, MEDVi, Ro and Mochi Health on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.